Kristin Renee Hobbie
Works (1)
Updated: July 5th, 2023 15:50
2009 journal article
Toward a molecular equivalent dose: Use of the medaka model in comparative risk assessment
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 149(2), 141–151.
author keywords: Risk assessment; Dose-response; DNA; Medaka; cll; Mutation; Adduct; DMN; Nitrosamines
MeSH headings : Animals; Animals, Genetically Modified; Carcinogens / metabolism; Carcinogens / pharmacology; Carcinogens / toxicity; DNA / genetics; DNA / isolation & purification; DNA Adducts / analysis; DNA Adducts / metabolism; Dimethylnitrosamine / metabolism; Dimethylnitrosamine / pharmacology; Dimethylnitrosamine / toxicity; Dose-Response Relationship, Drug; Guanine / analogs & derivatives; Guanine / analysis; Guanine / metabolism; Immunohistochemistry; Liver / drug effects; Liver / metabolism; Liver / pathology; Male; Models, Biological; Mutagenicity Tests; Mutation; Oryzias / genetics; Random Allocation; Rats; Rats, Inbred F344; Rats, Transgenic; Risk Assessment; Water Supply
topics (OpenAlex): Carcinogens and Genotoxicity Assessment; DNA Repair Mechanisms; Molecular Biology Techniques and Applications
TL;DR:
While liver DNA adduct concentrations were similar in magnitude, mutant frequencies in the DMN-exposed medaka were up to 20 times higher than in the Big Blue rats, and future work with other compounds will generate a more complete picture of comparative dose response between different phyletic levels and will help guide risk assessors using "Alternative" models.
(via Semantic Scholar)

UN Sustainable Development Goal Categories
3. Good Health and Well-being
(Web of Science)
Sources: Web Of Science, Crossref
Added: August 6, 2018